Pepscan have always had monster rep. really being an umbrella company & phylogicas work with them utilisaing CLIPS is indeed interesting although still very little is known about what is actually occuring there to the general market despite the optimisation of CD40l & other anti-inflammatory leads as released at the time of partnership almost 18 months ago. Their scienctific advisory board though does have high pedigree expecially with CAT founder (ex cambridge now Mediimune) along with Oxfords VC in the line. Still yet to hear anything about CD40's progress and even if something has been moved in-vivo. Pepscan do also have collaborations with Janssen which can only be a plus crossing links. Certainly a valuable technology partner we just need to see something come out of the partnership, at present as far as we know nothing has changed with no updates.
PYC Price at posting:
2.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)